ON 01910.Na
Showing 1 - 25 of 366
Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)
Recruiting
- Recessive Dystrophic Epidermolysis Bullosa
- Rigosertib Sodium
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)
Completed
- Myelodysplastic Syndrome (MDS)
- ON 01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1,
Completed
- Myelodysplastic Syndromes
-
Stanford, CaliforniaStanford University School of Medicine
Mar 23, 2020
Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)
Terminated
- Leukemia
- +3 more
- Rigosertib
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 5, 2020
Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)
Completed
- Lymphoma, Mantle-cell
- +4 more
- ON01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019
MDS Trial in France, Germany, United States (Oral rigosertib)
Completed
- Myelodysplastic Syndromes
- Oral rigosertib
-
Stanford, California
- +13 more
Jun 15, 2021
Myelodysplastic Syndrome Trial in New York (rigosertib)
Withdrawn
- Myelodysplastic Syndrome
-
New York, New YorkColumbia University Medical Center
Jun 29, 2020
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)
Active, not recruiting
- Hepatitis D, Chronic
- JNJ-73763989
- +4 more
-
Redwood City, California
- +68 more
Jan 17, 2023
Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Victoria, British Columbia, Canada
- +10 more
Jan 23, 2023
Chronic Hepatitis B Trial (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Herston, Queensland, Australia
- +7 more
Jan 23, 2023
Anxiety Disorder, Depressive Disorder Trial in Box Elder (Culturally Adapted Compass for Courage)
Recruiting
- Anxiety Disorder
- Depressive Disorder
- Culturally Adapted Compass for Courage
-
Bozeman, MontanaMontana State University
Oct 25, 2022
Sodium Deposition in Soft Tissues of Kidney Disease
Recruiting
- Haemodialysis Complication
- Measuring sodium content
-
London, Ontario, CanadaLHSC Regional Renal Care Program
Dec 21, 2022
Parkinson Disease Trial in Hangzhou (KL002 injection solution)
Not yet recruiting
- Parkinson Disease
- KL002 injection solution
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
May 22, 2023
Electrolyte Disorders in Prediabetics and in Type 2 Diabetes
Not yet recruiting
- Type 2 Diabetes Mellitus and Electrolyte Disorders
- (no location specified)
Apr 2, 2023
Gastric Cancer, Complication,Postoperative, Complications; Gastrointestinal, Postoperative Trial in Istanbul (MELD-Na score)
Completed
- Gastric Cancer
- +3 more
- MELD-Na score
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Aug 5, 2022
Alcohol Use Disorder Trial in Providence (Personalized Normative Feedback, Coping-Motive Specific Personalized Feedback
Not yet recruiting
- Alcohol Use Disorder
- Personalized Normative Feedback
- Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI)
-
Providence, Rhode IslandButler Hospital
Dec 5, 2022
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Eating Disorders Trial in Louisville (Personalized Treatment for Eating Disorders, Cognitive Behavioral Therapy for Eating
Recruiting
- Eating Disorders
- Personalized Treatment for Eating Disorders
- Cognitive Behavioral Therapy for Eating Disorders
-
Louisville, KentuckyEating Anxiety Treatment Laboratory and Clinic
Apr 13, 2022
Sweating Trial (water immersion)
Not yet recruiting
- Sweating
- water immersion
- (no location specified)
May 13, 2023
Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)
Completed
- Acute Myelocytic Leukemia
- +4 more
- ON 01910.Na
-
New York, New YorkMount Sinai Medical Center
Jan 9, 2018
Respiratory Distress Syndrome, Transient Tachypnea of Newborn Trial (Blood Gas Sampling)
Completed
- Respiratory Distress Syndrome
- Transient Tachypnea of Newborn
- Blood Gas Sampling
- (no location specified)
Aug 16, 2022